Abstract: 86Y (T1/2 = 14.74 h, 32% β+) has significant potential in theranostic applications as a simultaneous PET imaging partner to 90Y-labelled antibody therapy. However, the complex and costly nature of producing 86Y has led to this radiometal being difficult for institutes to obtain. The aim of this work was to develop a simple and cost-efficient method for safely producing 86Y. Our approach was twofold: to develop a method of target preparation that would significantly increase the cost efficiency of producing 86Y, and to design and construct an automated purification system that utilises the current Solid Target Laboratory facilities at the Austin Hospital to eliminate radiation handling risks and exposure.
Every year, IBA offers a scientific award for the best paper or abstract published in a scientific journal, proceedings of a conference using IBA equipment including cyclotron, targetry and/or chemistry.
Be the next winner: send your scientific publication to : Iba.email@example.com